Total Valuation
Hims & Hers Health has a market cap or net worth of €6.37B. The enterprise value is €8.74K.
Market Cap€6.37B
Enterprise Value€8.74K
Share Statistics
Hims & Hers Health has 223,080,080 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding223,080,080
Owned by Insiders5.21%
Owned by Institutions3.53%
Financial Efficiency
Hims & Hers Health’s return on equity (ROE) is 0.24 and return on invested capital (ROIC) is 6.02%.
Return on Equity (ROE)0.24
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)6.02%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee961.36K
Profits Per Employee52.57K
Employee Count2,442
Asset Turnover1.09
Inventory Turnover5.31
Valuation Ratios
The current PE Ratio of Hims & Hers Health is ―. Hims & Hers Health’s PEG ratio is -33.04.
PE Ratio―
PS Ratio3.11
PB Ratio13.50
Price to Fair Value13.50
Price to FCF98.76
Price to Operating Cash Flow26.50
PEG Ratio-33.04
Income Statement
In the last 12 months, Hims & Hers Health had revenue of 2.35B and earned 128.37M in profits. Earnings per share was 0.57.
Revenue2.35B
Gross Profit1.73B
Operating Income105.61M
Pretax Income123.92M
Net Income128.37M
EBITDA178.43M
Earnings Per Share (EPS)0.57
Cash Flow
In the last 12 months, operating cash flow was 266.84M and capital expenditures -176.96M, giving a free cash flow of 89.89M billion.
Operating Cash Flow266.84M
Free Cash Flow89.89M
Free Cash Flow per Share0.40
Dividends & Yields
Hims & Hers Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.76
52-Week Price Change-34.47%
50-Day Moving Average27.95
200-Day Moving Average25.29
Relative Strength Index (RSI)48.35
Average Volume (3m)6.38K
Important Dates
Hims & Hers Health upcoming earnings date is Nov 9, 2026, TBA (Confirmed).
Last Earnings DateAug 10, 2026
Next Earnings DateNov 9, 2026
Ex-Dividend Date―
Financial Position
Hims & Hers Health as a current ratio of 1.90, with Debt / Equity ratio of 477.13%
Current Ratio1.90
Quick Ratio1.61
Debt to Market Cap0.13
Net Debt to EBITDA5.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Hims & Hers Health has paid -4.44M in taxes.
Income Tax-4.44M
Effective Tax Rate-0.04
Enterprise Valuation
Hims & Hers Health EV to EBITDA ratio is 45.94, with an EV/FCF ratio of 110.82.
EV to Sales3.49
EV to EBITDA45.94
EV to Free Cash Flow110.82
EV to Operating Cash Flow27.32
Balance Sheet
Hims & Hers Health has €841.05M in cash and marketable securities with €1.55B in debt, giving a net cash position of -€705.19M billion.
Cash & Marketable Securities€841.05M
Total Debt€1.55B
Net Cash-€705.19M
Net Cash Per Share-€3.16
Tangible Book Value Per Share€0.30
Margins
Gross margin is 64.68%, with operating margin of 4.50%, and net profit margin of 5.47%.
Gross Margin64.68%
Operating Margin4.50%
Pretax Margin5.28%
Net Profit Margin5.47%
EBITDA Margin7.60%
EBIT Margin5.28%
Analyst Forecast
The average price target for Hims & Hers Health is €29.25, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€29.25
Price Target Upside16.72% Upside
Analyst ConsensusModerate Buy
Analyst Count11
Revenue Growth Forecast19.25%
EPS Growth Forecast-165.27%